ArticleBioMed research international2019
Clinical and Pathological Analysis of 4910 Patients Who Received Renal Biopsies at a Single Center in Northeast China.
Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 33 citations in OpenAlex.
- Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries.BMC nephrology · 2024Review
- Clinicopathologic features and long-term prognosis of hepatitis B virus-associated glomerulonephritis: a retrospective cohort study.Journal of nephrology · 2023Article
- Diagnosis and treatment of IgA nephropathy and IgA vasculitis nephritis in Chinese children.Pediatric nephrology (Berlin, Germany) · 2023Review
- Distribution of pathological types and epidemiological characteristics based on kidney biopsy in Northwest China.Kidney research and clinical practice · 2023Article
- Causes of nephrotic syndrome in Sweden: The relevance of clinical presentation and demographics.Frontiers in nephrology · 2023Article
- Associations of left renal vein entrapment with IgA nephropathy and Henoch-Schönlein purpura nephritis.Renal failure · 2022Article
- Changes in the spectrum of kidney diseases: a survey of 2803 patients from 2010 to 2018 at a single center in southeastern China.Renal failure · 2022Article
- Spectrum of biopsy-proven kidney diseases in northwest China: a review of 30 years of experiences.International urology and nephrology · 2022Review
- Morphological Spectrum of Glomerulonephritis in Medical Renal Biopsies: A Single-Center Study.Cureus · 2022Article
- The spectrum of biopsy-proven glomerular diseases in a tertiary Hospital in Southern Brazil.BMC nephrology · 2021Article
- Kidney biopsy in very elderly patients: indications, therapeutic impact and complications.BMC nephrology · 2021Article
- Hepatitis B Virus-Related Glomerulonephritis with Positive and Negative Serum HBsAg: Different Clinicopathologic Characteristics of Two Clinical Subtypes.International journal of general medicine · 2021Article
- sPLA2-IB Level Correlates with Hyperlipidemia and the Prognosis of Idiopathic Membranous Nephropathy.Current medical science · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo identify the epidemiology and pathological types of kidney diseases and their changes during the past decade, in a population from Northeast China.
methodsWe retrospectively analysed clinical and renal pathological data from 4910 patients who received renal biopsies in the Second Hospital of Jilin University from 2008 to 2017.
resultsMales received more renal biopsies than females (
conclusionFrom 2008 to 2017, renal biopsies were increasingly performed in the elderly. There were notable changes in the epidemiology and pathological types of kidney disease among renal biopsy patients at our centre.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.